Oral drugs are on the horizon.
New scanning device may replace liver biopsy.
Added diagnoses of HIV, hepatitis C can also cause bone loss.
CDC urges baby boomer testing; new drugs in development.
Boceprevir and telaprevir were approved for treatment of hepatitis C in May 2011.
The release of two new oral medications marks another significant advance in the fight against hepatitis C.
Potential candidates for the new hepatitis C drugs will need to consider the drugs’ price, which will be added to the already steep cost of interferon and ribavirin.
The FDA approved telaprevir, a new hepatitis C drug, after recently approving another new drug, boceprevir. Both are protease inhibitors.
For years, patients with hepatitis C have complained of loss of concentration, memory lapses and shortened attention span. Is there something to this?
Activists call for people with bleeding disorders, who are typically excluded from clinical trials for hepatitis C, to be given emergency access to promising new drugs being studied.
Liver transplants can have good outcomes if patients know what to ask their hematologist, when to confer with a hepatologist and when to be listed in a national liver transplant database.
Print out these simple steps to make sure you get evaluated in a timely manner and placed on a liver transplant list, if appropriate.
For patients with hemophilia, the surgery is often complicated by hepatitis C and HIV.
Researchers found antibodies that neutralize various forms of HCV in mice.
For people with hemophilia and hepatitis C, the question is whether new techniques are viable alternatives to liver biopsy, considered the gold standard for diagnosing the extent of liver disease.